Search results for: Multi-Indication Medicines
Filter search results
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?
1 June 2022
…known monogenic (single gene) cause. In contrast to traditional small molecule medicines, gene therapies have the potential to correct underlying genetic defects, offering the potential for transformational health gains rather…
Martina Garau
22 May 2014
…countries; HTA reforms and collaborations; measuring and incorporating societal impacts of interventions in decision-making; economic issues posed by the development and provision of orphan medicines; paying for innovative therapies, including…
Mikel Berdud
26 February 2015
…research includes the analysis of the life-cycle value of medicines, social surplus created by new health technologies and its distribution, the economics of anti-microbial resistance including push and pull incentive…
Nadine Henderson
26 September 2019
…Advisory Board of CMAC, a medicines manufacturing research centre led from the University of Strathclyde. She has a MSc in Health Economics from the University of York and a BSc…
Supporting the Era of Green Pharmaceuticals in the UK
1 November 2022
…to be taken now by governments, health systems, medicines regulators and companies globally to secure the era of green pharmaceuticals. The core analysis for this report was undertaken before the…
Mike Paulden – 2022 Prize Finalist
18 January 2023
…medicines and other health technologies. His research on time preference and discounting has contributed towards guidelines used for economic evaluations in Canada and elsewhere. He has a particular interest in…
Claud Theakston
26 January 2023
…and processes across countries, as well as the broader value of medicines to society and how health economics can help us respond to and prepare for challenges and demographic changes….
Siva Anandaciva
3 February 2023
…in the Department of Health working on medicines policy and urgent and emergency care. Siva is a member of the Office of Health Economics policy committee and chairs the National…
Matthias Hofer
5 April 2023
…research into the industrial organisation, manufacturing capabilities, productivity, and competitiveness of the UK pharmaceutical sectors. He has also worked at the European Medicines Agency and UK Research and Innovation, where…